Element Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-22,520	Closed	-$143K	–	936
2018 Q2	$143K	Buy	22,520 +8,376	+59%	+$53.2K	﹤0.01%	779
2018 Q1	$67K	Buy	+14,144	New	+$67K	﹤0.01%	791